WebDisclosure WebDisclosure
Basculer en Français
11103 Companies
244238 Keywords
172332 Articles
131606 Press releases
Headlines Articles Press releases Public Health Vaccines Remove
  1. Home
  2. Companies
  3. Public Health Vaccines
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/21/2024 at 13:05, 2 years 6 months ago

    Public Health Vaccines Initiates First Clinical Trial for Marburg Virus Vaccine

    Phase 1 Clinical Trial Marburg Virus Vaccine Public Health Vaccines RVSV Vector Platform Emerging Infectious Diseases
  • BRIEF

    published on 03/21/2024 at 13:05, 2 years 6 months ago

    Public Health Vaccines lance le premier essai clinique pour le vaccin contre le virus de Marburg

    Essai Clinique De Phase 1 Vaccin Contre Le Virus De Marburg Vaccins De Santé Publique Plateforme Vectorielle RVSV Maladies Infectieuses Émergentes
  • PRESS RELEASE

    published on 03/21/2024 at 13:00, 2 years 6 months ago

    Public Health Vaccines Announces Initiation of First Clinical Trial Evaluating Its Marburg Virus Vaccine

    Public Health Vaccines, LLC initiates Phase 1 clinical trial for single-dose vaccine against Marburg virus, with BARDA funding up to $72 million for development. Company aims for global preparedness against infectious diseases
    Phase 1 Clinical Trial Marburg Virus Vaccine Public Health Vaccines LLC BARDA Funding Global Preparedness
    Logo of Public Health Vaccines
Accesswire
  • Published on 09/30/2026 at 15:50, 3 hours 43 minutes ago

    Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans

  • Published on 09/30/2026 at 14:37, 4 hours 56 minutes ago

    NuRAN Leverages Starlink Backhaul to Drive Higher Revenue Per Rural Site

  • Published on 09/30/2026 at 14:31, 5 hours 2 minutes ago

    First Breach Expands Ammunition Manufacturing Operations to Seven Days a Week

  • Published on 09/30/2026 at 14:07, 5 hours 26 minutes ago

    Worksport COR Energy System Now Available Through Amazon

  • Published on 09/30/2026 at 13:30, 6 hours 3 minutes ago

    Nextech3D.ai Engages MZ Group to Lead Strategic Investor Relations Program

View all ACCESSWIRE
EQS Group
  • Published on 09/30/2026 at 18:39, 54 minutes ago

    Advanced Blockchain AG Publishes 2026 Half-Year Report and Advances ABAG 2.0 Strategy

  • Published on 09/30/2026 at 18:26, 1 hour 7 minutes ago

    Kaufman & Broad SA: RESULTATS DES NEUF PREMIERS MOIS DE 2026

  • Published on 09/30/2026 at 18:26, 1 hour 7 minutes ago

    Kaufman & Broad SA: RESULTS FOR THE FIRST NINE MONTHS OF 2026

  • Published on 09/30/2026 at 18:13, 1 hour 20 minutes ago

    Freelance.com: Mise à disposition du document d'enregistrement universel 2025

  • Published on 09/30/2026 at 18:12, 1 hour 21 minutes ago

    BOOSTER Precision Components Holding announces prolongation of standstill agreement with Ad-hoc Group

View all EQS
Les Echos
  • Published on 09/30/2026 at 18:44, 48 minutes ago

    Broadcast of the 5th edition of “On the way up”

  • Published on 09/30/2026 at 18:44, 48 minutes ago

    Diffusion de la 5e édition de “On the way up”

  • Published on 09/30/2026 at 18:18, 1 hour 15 minutes ago

    Nombre total de droits de vote et d'actions composant le capital social

  • Published on 09/30/2026 at 18:15, 1 hour 18 minutes ago

    The Belgian State and ENGIE Group have agreed to extend the target date for concluding the Heads of Terms until 4 november 2026

  • Published on 09/30/2026 at 18:15, 1 hour 18 minutes ago

    L’État belge et le groupe ENGIE ont convenu de reporter au 4 novembre 2026 la date cible pour la conclusion des Heads of Terms

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy